Kelli O'Connell

8PUBLICATIONS
87CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 29, 2026
Uncovering hypothesis-generating associations between prescription drugs and digestive cancer risk: a case-control drug-wide association study (DWAS).

|Dec 11, 2025
Clinician- and Facility-Level Factors Associated With Receipt of Nonguideline Chemotherapy Regimens in Women With Stage I-IIIA Breast Cancer.

Yashasvini Sampathkumar, Ziad Zakaria, Kelli O'Connell

|Feb 14, 2025
Methodologic Approach to Defining Comorbidities in a Cohort of Patients With Cancer: An Example in the Optimal Breast Cancer Chemotherapy Dosing Study.

Peng Wang, Kelli O'Connell, Jenna Bhimani

|Sep 05, 2024
Understanding risk factors for endometrial cancer in young women.

Noah Charles Peeri, Kimberly A Bertrand, Renhua Na

|Jul 25, 2024
Patient Characteristics Associated with Intended Nonguideline Chemotherapy in Women with Stage I to IIIA Breast Cancer.

Jenna Bhimani, Kelli O'Connell, Sonia Persaud

|Apr 18, 2024
Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With Breast Cancer.

Jenna Bhimani, Kelli O'Connell, Isaac J Ergas

Pageof 2

Frequent Collaborators

6 joint publications

Elizabeth D Kantor

5 joint publications

Grace Gallagher

5 joint publications

Candyce H Kroenke

5 joint publications

Lawrence H Kushi